Furthermore, based on the results obtained from clinical samples, we examined the mechanism by which GPNMB contributes to tumor progression, assuming that a cross talk between GPNMB and HER2 exists through shared signaling pathways. The gene discussed is ERBB2; the disease is neoplasm.